NCT06715826RecruitingPhase 1/2
Target-specific immunoPET Imaging of Breast Cancer
Development and Clinical Translation of immunoPET Imaging Probes for Breast Cancer
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Brief summary (registry, in English)
The aim of this study is to establish and optimize the Trop2/HER2-targeted PET/CT imaging method, and its physiological and pathological distribution characteristics, on the basis of which the diagnostic efficacy of the above imaging agents in breast cancer will be evaluated.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 29 Nov 2024
- Start date
- 21 Sept 2024
- Primary completion date
- Nov 2026
- Lead sponsor
- RenJi Hospital
- Diseases
- Metastatic breast cancer
- NCT number
- NCT06715826
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 200
- From 21 Sept 2024 to the primary completion date, Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe hepatic and renal insufficiency;
- History of serious surgery in the last month;
- Allergic to antibody or single-domain antibody radiopharmaceuticals.
Other
- Pregnancy；
Who the study is looking for
- Aged 18-75 years old and of female gender；
- Histologically confirmed diagnosis of breast cancer or suspected breast cancer by diagnostic imaging;
- Capable of giving signed informed consent, including compliance with the requirements and restrictions listed in the informed consent form (ICF) and this protocol.
Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.